Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Francisco Leyva , Mauro Biffi , Howard Marshall , et al Added: 3 years ago
Prof Francisco Leyva and Prof Mauro Biffi introduce this online video series, filmed in partnership with the BHRS. Through a series of 8 videos, they explain how faculty aim to draw parallels on hospital responses during the COVID-19 crisis and assess how treating patients in cardiology has been during this period and how cardiologists will continue to operate in what will be the new ‘normal’. View more
Author(s): Haran Burri Added: 3 years ago
Remote follow-up and monitoring of patients implanted with cardiac implantable electronic devices (CIEDs) has been introduced over a decade ago, and is now indicated according to European (class IIa indication1) and American (class I indication2) guidelines. There have been high expectations that this technology will improve patient outcome, as it significantly shortens response to actionable… View more
Author(s): Niraj Varma , Renato Pietro Ricci , Loredana Morichelli Added: 3 years ago
Monitoring after implant of patients with cardiac implantable electronic devices (CIED) forms a part of both device and patient care, and is the responsibility of the implanting centre. Monitoring is challenged by the increasing number and technical complexity of implanted devices coupled with the increasing clinical complexity of the patient population. Current practice is based on quarterly to… View more
Author(s): Thorsten Lewalter , Giuseppe Boriani Added: 3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable… View more
Author(s): Irina Suman-Horduna , Sonya Babu-Narayan , Sabine Ernst Added: 3 years ago
Catheter ablation has moved from ablation of ‘simple’ substrates like accessory pathways,1 atrioventricular nodal re-entrant tachycardias (AVNRTs)2 and re-entrant or focal tachycardia (of either ventricular or atrial origin)3–5 in recent years to more complex arrhythmias such as atrial or ventricular tachycardia (VT) or fibrillation.6–8 Even patients with complex congenital heart disease that may… View more
Author(s): David Filgueiras-Rama , Jose L Merino Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia in the clinical practice.1 The prevalence of the arrhythmia is progressively increasing in developed countries and moreover, it is expected to affect up to 12 million people only in the US by 2050.2 Antiarrhythmic drugs continue to represent the first-line of treatment in AF patients, either to restore sinus rhythm or to prevent… View more